igf-1 lr3 protocol Dosage: What to Know About Dosing, Safety, and Clinical Use Measurement of IGF-1 by MSIA-SRM

Badgujar et al

placebo, plb

Discussion Tamoxifen, a non-steroidal anti-estrogen, has been used for decades in the treatment of estrogen-receptor positive breast cancer

Featured NAC Article: von Willebrands Factor & NAC N-acetylcysteine reduces the size and activity of von Willebrands Factor in human plasma and mice From the article Discussion: Our experiments demonstrate that NAC has many effects that could be of benefit in TTP and other thrombotic disorders involving hyperreactive forms of vWF

Summary paraphrased from the peer-reviewed preclinical literature

Drop back to the last tolerated dose and stay there for 6-8 weeks before attempting escalation again